Clearpoint Neuro Inc
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser cat… Read more
Clearpoint Neuro Inc (CLPT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.197x
Based on the latest financial reports, Clearpoint Neuro Inc (CLPT) has a cash flow conversion efficiency ratio of -0.197x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.12 Million) by net assets ($15.87 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Clearpoint Neuro Inc - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Clearpoint Neuro Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Clearpoint Neuro Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Clearpoint Neuro Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AES Brasil Energia S.A
SA:AESB3
|
0.008x |
|
Harworth Group plc
PINK:HWGLF
|
N/A |
|
EuBiologics Co. Ltd.
KQ:206650
|
0.113x |
|
Alma Media Oyj
HE:ALMA
|
0.088x |
|
Continental Holdings Corp
TW:3703
|
0.024x |
|
Aviat Networks Inc
NASDAQ:AVNW
|
0.088x |
|
Beijing Huaru Technology Co. Ltd.
SHE:301302
|
-0.065x |
|
Zhejiang Zuch Technology Co. Ltd. A
SHE:301280
|
N/A |
Annual Cash Flow Conversion Efficiency for Clearpoint Neuro Inc (2011–2024)
The table below shows the annual cash flow conversion efficiency of Clearpoint Neuro Inc from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $25.39 Million | $-8.95 Million | -0.353x | +45.60% |
| 2023-12-31 | $21.17 Million | $-13.72 Million | -0.648x | -47.85% |
| 2022-12-31 | $36.89 Million | $-16.17 Million | -0.438x | -68.41% |
| 2021-12-31 | $48.79 Million | $-12.70 Million | -0.260x | +92.08% |
| 2020-12-31 | $2.38 Million | $-7.81 Million | -3.285x | -428.66% |
| 2019-12-31 | $4.59 Million | $-2.85 Million | -0.621x | +79.72% |
| 2018-12-31 | $1.51 Million | $-4.63 Million | -3.065x | -198.08% |
| 2017-12-31 | $5.83 Million | $-5.99 Million | -1.028x | -113.36% |
| 2016-12-31 | $-756.07K | $-5.82 Million | 7.698x | +76.55% |
| 2015-12-31 | $-1.98 Million | $-8.64 Million | 4.360x | -93.97% |
| 2014-12-31 | $-100.33K | $-7.25 Million | 72.265x | +6249.42% |
| 2013-12-31 | $-6.83 Million | $-7.78 Million | 1.138x | -12.16% |
| 2012-12-31 | $-5.74 Million | $-7.43 Million | 1.296x | +353.61% |
| 2011-12-31 | $-21.84 Million | $-6.24 Million | 0.286x | -- |